P390. To double dose or not to double dose? That is the question: Single centre experience in the use of infliximab antibodies and levels in a paediatric IBD (pIBD) cohort | Zendy

AI Assistant Blog Pricing

P390. To double dose or not to double dose? That is the question: Single centre experience in the use of infliximab antibodies and levels in a paediatric IBD (pIBD) cohort

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.